Australia - English - Department of Health (Therapeutic Goods Administration)

comvita australia pty ltd - propolis dry extract, quantity: 2.08 mg/ml (equivalent: lead, qty 10 microgram/g); echinacea purpurea, quantity: 5.72 mg/ml (equivalent: echinacea purpurea, qty 257 mg/ml); honey, quantity: 130 mg/ml - oral liquid - excipient ingredients: melaleuca oil; eucalyptus oil; fennel oil; silicon dioxide; glucose monohydrate; honey; carrageenan; calcium phosphate; purified water; apple cider vinegar; xanthan gum; peppermint oil; clove leaf oil - antioxidant/reduce free radicals formed in the body ; traditionally used in naturopathic medicine to demulcent/soothe irritated tissues ; traditionally used in western herbal medicine to helps reduce occurrence of common colds ; traditionally used in western herbal medicine to decrease/reduce/relieve common cold duration ; traditionally used in western herbal medicine to decrease/reduce/relieve the severity of symptoms of mild upper respiratory tract infections ; traditionally used in western herbal medicine to helps reduce occurrence of symptoms of upper respiratory tract infections ; traditionally used in western herbal medicine to decrease/reduce/relieve symptoms of common cold ; decrease/reduce/relieve cough

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

a. menarini singapore pte. ltd. - ginkgo biloba (folium) standardized extract -

United States - English - NLM (National Library of Medicine)

pacifica beauty llc. - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - acne medication for the treatment of acne.

Australia - English - Department of Health (Therapeutic Goods Administration)

origio australasia pty ltd - 42850 - in vitro fertilization culture medium kit - cuture media kit consisting of 2 solutions, equilibration solution and vitrification solution. equilibration solution is gradually added to media containing specimen to be vitrified over time until equilibrated. specimen is then added to vitrification solution before transfer to carrier for vitrification (snap frozen in liquid nitrogen). intended for vitrification of human oocytes (mii), cleavage stage embryos and blastocysts.

Australia - English - Department of Health (Therapeutic Goods Administration)

origio australasia pty ltd - 42850 - in vitro fertilization culture medium kit - contains 3 solutions, 1.0 m sucrose warming solution, 0.5 m sucrose warming solution & mops solution. specimen to be warmed is transferred from vitrification carrier into 1.0 m sucrose warming solution at 35-37 degrees for 1 minute before transfer to 0.5 m sucrose warming solution for 3 minutes. then moved to 2 successive drops of mops solution each for 5 minutes before transfer to preferred media. intended for warming of human oocytes (mii), cleavage stage embryos and blastocysts.

Australia - English - Department of Health (Therapeutic Goods Administration)

g & m therapy pty ltd - 34488 - massager, electrical, bed/chair - an electrical massage bed / chair designed to assist people with mobility and relaxation.

United States - English - NLM (National Library of Medicine)

sage therapeutics, inc. - brexanolone (unii: s39xz5qv8y) (brexanolone - unii:s39xz5qv8y) - zulresso is indicated for the treatment of postpartum depression (ppd) in patients 15 years and older [see clinical studies (14)] . none. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antidepressants during pregnancy. healthcare providers are encouraged to register patients by calling the national pregnancy registry for antidepressants at 1-844-405-6185 or visiting online at https://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/antidepressants/ . risk summary based on findings from animal studies of other drugs that enhance gabaergic inhibition, zulresso may cause fetal harm. available data from case reports with zulresso use in pregnant women are insufficient to establish a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. in animal reproduction studies, malformations were not seen in rats or rabbits at plasma levels up to 5 and 6 times the maximum recomme

Australia - English - Department of Health (Therapeutic Goods Administration)

arjo australia pty ltd - 32266 - massage table/couch, non-powered, non-portable - the therapy couches are suitable for a wide range of medical, therapy examination and minor treatment procedures. the couches should be operated by trained medical personnel or clinician: the therapy range has a safe working load of 240kg (529lb). the therapy bobath and mat table have a safe working load of 250kg (551lb). the deluxe bobath couch has a safe working load of 325kg (716lb).

Australia - English - Department of Health (Therapeutic Goods Administration)

arjo australia pty ltd - 32264 - massage table/couch, line-powered - the therapy couches are suitable for a wide range of medical, therapy examination and minor treatment procedures. the couches should be operated by trained medical personnel or clinician: the therapy range has a safe working load of 240kg (529lb). the therapy bobath and mat table have a safe working load of 250kg (551lb). the deluxe bobath couch has a safe working load of 325kg (716lb).

Australia - English - Department of Health (Therapeutic Goods Administration)

natures choice pty ltd - vitis vinifera -